IP Library Patent Application 11343858
Patent Application
App. No. 11/343,858

Method and kit for the collection and maintenance of the detectability of a plurality of microbiological species in a single gynecological sample

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/343,858
Abstract

A method and kit related thereto are described for the collection and maintenance of detectability of a plurality of species of microbiological agents selected from the group consisting of bacteria, fungi, viruses, and protozoa, in a single gynecological sample which comprises providing transport media in a resealable container and instructions for preparation and handling of the gynecological sample and a written indication of the detectability of a plurality of species.

Claims (23)

1 . A method for the collection and maintenance of detectability of a plurality of species of microbiological agents selected from the group consisting of bacteria, fungi, and viruses, in a single gynecological sample comprising:

providing transport media in a resealable container and instructions for preparation and handling of a gynecological sample and an indication of the detectability of the plurality of species wherein the plurality of species comprise at least one species selected from the group consisting of Molluscum contagiosum Virus, Mycoplasma genitalium, Mycoplasma hominis, Candida dubliniensis, Candida krusei, Candida lusitaneae, Atopobium vaginae, erythromycin-resistant Streptococcus agalactiae, clindamycin-resistant Streptococcus agalactiae, Lymphogranuloma venereum, HPV-16, HPV-18, HPV-31, HPV-33, HPV-35, HPV-39, HPV-45, HPV-51, HPV-52, HPV-56, HPV-58, HPV-59, HPV-66, HPV-68, HPV-6/11, HPV-42, HPV-43, and HPV-44.

2 . The method according to claim 1 wherein a presence of any species within the plurality of species is indicative of at least one gynecological disorder.

3 . The method according to claim 2 wherein the presence of any species within the plurality of species is indicative of an infectious disease or vaginosis.

4 . The method according to claim 1 wherein the plurality of species is selected from the group consisting of Bacteroides fragilis, Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, Chlamydia trachomatis, Gardnerella vaginalis, Haemophilis ducreyi, Herpes simplex virus subtype 1 (HSV-1), Herpes simplex virus subtype 2 (HSV-2), Human papillomavirus (HPV), Mobiluncus mulieris, Mobiluncus curtisii, Molluscum contagiosum Virus, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Treponema pallidum, Trichomonas vaginalis, Ureaplasma urealyticum, and Streptococcus agalactiae (Group B Streptococcus ).

5 . The method according to claim 4 for the collection and maintenance of the detectability of at least 3 species within the plurality of species.

6 . The method according to claim 5 for the collection and maintenance of the detectability of at least 4 species within the plurality of species.

7 . The method according to claim 6 for the collection and maintenance of the detectability of at least 5 species within the plurality of species.

8 . The method according to claim 7 for the collection and maintenance of the detectability of at least 6 species within the plurality of species.

9 . The method according to claim 4 for the collection and maintenance of the detectability of the plurality of species comprising Neisseria gonorrhoeae and Chlamydia trachomatis.

10 . The method according to claim 9 for the collection and maintenance of the detectability of the plurality of species comprising Trichomonas vaginalis.

11 . The method according to claim 4 for the collection and maintenance of the detectability of the plurality of species comprising Gardnerella vaginalis, Mobiluncus mulieris, Mobiluncus curtisii, and Bacteroides fragilis.

12 . The method according to claim 4 for the collection and maintenance of the detectability of the plurality of species comprising Candida albicans, Candida glabrata, Candida parapsilosis, and Candida tropicalis.

13 . The method according to claim 4 for the collection and maintenance of the detectability of the plurality of species comprising Herpes simplex virus subtype 1 (HSV-1) and Herpes simplex virus subtype 2 (HSV-2).

14 . The method according to claim 13 for the collection and maintenance of the detectability of the plurality of species comprising Treponema pallidum and Haemophilis ducreyi.

15 . A kit for the collection and maintenance of detectability of a plurality of species of microbiological agents selected from the group consisting of bacteria, fungi, viruses, and protozoa, in a single gynecological sample comprising:

transport media in a resealable container, a sterile swab, and instructions for preparation and handling of a gynecological sample and a writing which indicates the detectability of the plurality of species wherein the plurality of species comprise at least one species selected from the group consisting of Molluscum contagiosum Virus, Mycoplasma genitalium, Mycoplasma hominis, Candida dubliniensis, Candida krusei, Candida lusitaneae, Atopobium vaginae, erythromycin-resistant Streptococcus agalactiae, clindamycin-resistant Streptococcus agalactiae, Lymphogranuloma venereum, HPV-16, HPV-18, HPV-31, HPV-33, HPV-35, HPV-39, HPV-45, HPV-51, HPV-52, HPV-56, HPV-58, HPV-59, HPV-66, HPV-68, HPV-6/11, HPV-42, HPV-43, and HPV-44.

16 . The kit according to claim 15 wherein the plurality of species is selected from the group consisting of Bacteroides fragilis, Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, Chlamydia trachomatis, Gardnerella vaginalis, Haemophilis ducreyi, Herpes simplex virus subtype 1 (HSV1), Herpes simplex virus subtype 2 (HSV2), Human papillomavirus (HPV), Mobiluncus mulieris, Mobiluncus curtisii, Molluscum contagiosum Virus, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Treponema pallidum, Trichomonas vaginalis, Ureaplasma urealyticum, and Streptococcus agalactiae (Group B Streptococcus ).

17 . The kit according to claim 16 for the collection and maintenance of the detectability of at least 3 species within the plurality of species.

18 . The kit according to claim 17 for the collection and maintenance of the detectability of at least 4 species within the plurality of species.

19 . A method of using a kit for collection and maintenance of detectability of a plurality of species, wherein the kit comprises transport media in a resealable container and instructions for preparation and handling of a gynecological sample and an indication of the detectability of a plurality of species of microbiological agents selected from the group consisting of bacteria, fungi, viruses, and protozoa in the gynecological sample, comprising:

collecting a clinical sample of a gynecological environment in the transport media wherein the plurality of species comprise at least one species selected from the group consisting of Molluscum contagiosum Virus, Mycoplasma genitalium, Mycoplasma hominis, Candida dubliniensis, Candida krusei, Candida lusitaneae, Atopobium vaginae, erythromycin-resistant Streptococcus agalactiae, clindamycin-resistant Streptococcus agalactiae, Lymphogranuloma venereum, HPV-16, HPV-18, HPV-31, HPV-33, HPV-35, HPV-39, HPV45, HPV-51, HPV-52, HPV-56, HPV-58, HPV-59, HPV-66, HPV-68, HPV-6/11, HPV-42, HPV-43, and HPV-44.

20 . The method according to claim 19 wherein the plurality of species is selected from the group consisting of Bacteroides fragilis, Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, Chlamydia trachomatis, Gardnerella vaginalis, Haemophilis ducreyi, Herpes simplex virus subtype 1 (HSV1), Herpes simplex virus subtype 2 (HSV2), Human papillomavirus (HPV), Mobiluncus mulieris, Mobiluncus curtisii, Molluscum contagiosum Virus, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Treponema pallidum, Trichomonas vaginalis, Ureaplasma urealyticum, and Streptococcus agalactiae (Group B Streptococcus ).

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2018
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: MEDICAL DIAGNOSTIC LABORATORIES L. L. C.
Reel/Frame 046354/0817 →
SECURITY INTEREST Recorded Apr 27, 2018
From: MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
To: TD BANK, N.A.
Reel/Frame 046031/0381 →
SECURITY INTEREST Recorded Mar 1, 2016
From: MEDICAL DIAGNOTIC LABORATORIES, L.L.C.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 037963/0744 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2015
From: ADELSON, MARTIN; MORDECHAI, ELI
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 036274/0387 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2006
From: ADELSON, MARTIN E.; MORDECHAI, ELI
To: MEDICAL DIAGNOSTIC LABORATORIES LLC
Reel/Frame 017558/0153 →